Goldman Sachs Knock-Out LLY/ DE000GG2ZV92 /
2024-06-24 8:52:35 PM | Chg.- | Bid9:44:14 AM | Ask9:44:14 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
21.98EUR | - | 21.43 Bid Size: 2,000 |
21.58 Ask Size: 2,000 |
Eli Lilly and Co | 661.8412 USD | 2078-12-31 | Call |
GlobeNewswire
06-21
HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
GlobeNewswire
06-11
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire
06-10
Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...
GlobeNewswire
06-06
Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
GlobeNewswire
05-30
Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire
05-30
Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire
05-24
Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
GlobeNewswire
05-16
BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire
05-16
Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire
05-13
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-13
Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire
05-08
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update